Citadel Advisors - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 65 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$666,180
-64.9%
176,238
-37.8%
0.00%
Q2 2023$1,899,772
+245.0%
283,548
+235.3%
0.00%
Q1 2023$550,589
+34.8%
84,576
+76.6%
0.00%
Q4 2022$408,562
-29.4%
47,897
-56.3%
0.00%
Q3 2022$579,000
-64.1%
109,670
-71.2%
0.00%
Q2 2022$1,615,000
+135.8%
380,966
+95.2%
0.00%
Q1 2022$685,000
+10.0%
195,156
+108.6%
0.00%
Q4 2021$623,000
-16.2%
93,565
+25.6%
0.00%
Q3 2021$743,000
-30.6%
74,492
+115.0%
0.00%
Q2 2021$1,070,000
-83.3%
34,648
-74.9%
0.00%
-100.0%
Q4 2020$6,401,000138,1380.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders